Sentence examples for pharmaceutical royalties from inspiring English sources

DuPont has exceeded estimates in each of the nine quarters that Ellen J. Kullman has been chief executive, even as expiring drug patents cut pharmaceutical royalties.

DuPont forecasts earnings per share growth of at least 10.0% between 2008 and 2010, despite anticipated declines in pharmaceutical royalties after patents expire in 2010.

What became clear to me during this time is the immense opportunity to be the liquidity provider in a market (existing or new) where there are valuable assets (be they real estate or pharmaceutical royalties) that are, under the status quo, under-monetized.

Moreover, the total revenue from technology transfer in US universities and research hospitals is "dominated by a few very large royalties from fewer than 1% of total patents" and is uneven over time: "pharmaceutical royalties are high – but very rare," and "equity cash-ins from spin-outs are only occasionally large, and are one-time" [ 93].

TUCKED into a residential neighborhood in Princeton, the American Boychoir School occupies 17 rustic acres crowned by Albemarle, the Georgian mansion once home to pharmaceutical royalty, Gerard Barnes Lambert and his wife, Grace.

It wasn't until the following summer while I was working for the founder of a pharmaceutical royalty company, Royalty Pharma, and watching Airbnb make waves during the Democratic National Convention, that I would fully grasp the potential of marketplaces.

Eli Lilly & Company won an appeals court ruling on Friday that threw out a $65.2 million verdict won by Ariad Pharmaceuticals over royalties on the osteoporosis drug Evista and the sepsis medicine Xigris.

Royalty Pharma, which invests in royalties of pharmaceutical products, is taking aim at Elan's new deal-making plan.

Parares (Pareras 2008b) calls companies following this model "royalty income pharmaceutical companies".

For example, a royalty structure could be implemented that would allow pharmaceutical companies to receive a royalty, from generic drug companies, for example, for sponsoring a phase III trial with a generic repurposed drug and getting FDA and payer approval.

Antibiotics have also helped to elucidate several biological mechanisms and boosted the birth and growth of pharmaceutical companies, generating profits and royalties.